Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer

Conclusion Our data support the hypothesis that SBRT has non-inferior efficacy and toxicity rates as IMRT. Given the lower cost and convenience for patients, SBRT may be considered as an alternative treatment for localized prostate cancer.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research